Case number 1:22-cv-00899
AstraZeneca AB et al v. USV Private Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 30, 2023 | 16 | PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals, LP. (Joyce, Alexandra) Modified on 1/30/2023 (nms). (Entered: 01/30/2023) (4) |
| Jan 30, 2023 | 17 | CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 1/30/2023. (nms) (Entered: 01/30/2023) (4) |
| Jan 30, 2023 | 18 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1 Consent Judgment)(nms) (Entered: 01/30/2023) (Main Document) (1) |
| Jan 30, 2023 | 18 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1 Consent Judgment)(nms) (Entered: 01/30/2023) (Consent Judgment) (4) |
| Jan 10, 2023 | 14 | ORAL ORDER: An answer was due to be filed on 1/6/2023 (see D.I. 13 ), and to date none has been filed. Now the Plaintiff shall file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 1/10/2023. (nms) (Entered: 01/10/2023) (0) |
| Jan 10, 2023 | 15 | STIPULATION and [Proposed] Order to Extend Time, by AstraZeneca AB, AstraZeneca Pharmaceuticals, LP. (Silver, Daniel) Modified on 1/10/2023 (nms). (Entered: 01/10/2023) (2) |
| Dec 6, 2022 | 13 | STIPULATION and Proposed Order to Extend Time - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) Modified on 12/6/2022 (nms). (Entered: 12/06/2022) (2) |
| Nov 1, 2022 | 12 | STIPULATION TO EXTEND TIME Defendants' deadline to answer, move or otherwise respond to the Complaint to December 7, 2022 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 11/01/2022) (2) |
| Oct 5, 2022 | 11 | STIPULATION TO EXTEND TIME for Defendants' deadline to answer, move or otherwise respond to the Complaint to November 7, 2022 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 10/05/2022) (2) |
| Aug 25, 2022 | 10 | STIPULATION TO EXTEND TIME Defendants' Deadline to Answer, Move or Otherwise Respond to the Complaint to October 6, 2022 (from September 6, 2022) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 08/25/2022) (2) |
| Jul 6, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 6, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For USV Private Ltd. waiver sent on 7/5/2022, answer due 9/6/2022. (Joyce, Alexandra) |
| Jul 6, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For USV North America, Inc. waiver sent on 7/5/2022, answer due 9/6/2022. (Joyce, Alexandra) |
| Jul 5, 2022 | 7 | Main Document (2) Docket Text: Summons Issued as to USV North America, Inc. on 7/5/2022; USV Private Ltd. on 7/5/2022. (Attachments: # (1) Summons Issued)(smg) |
| Jul 5, 2022 | 7 | Summons Issued (2) |
| Jul 1, 2022 | 1 | Main Document (12) Docket Text: COMPLAINT for PATENT INFRINGEMENT - filed against USV North America, Inc., USV Private Ltd. ( Filing fee $ 402, receipt number ADEDC-3908922.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(smg) |
| Jul 1, 2022 | 1 | Exhibit A (76) |
| Jul 1, 2022 | 1 | Civil Cover Sheet (3) |
| Jul 1, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jul 1, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 18, 2022. Date of Expiration of Patent: 1/27/2036 (7/27/2036 with pediatric exclusivity).Thirty Month Stay Deadline: 11/18/2024. (smg) |
| Jul 1, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (smg) |
| Jul 1, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (smg) |
| Jul 1, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (smg) |
